These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37329694)

  • 1. Clinical performance, audiological outcomes, and quality of life of the Cochlear Osia ® system.
    Young A; Fechtner L; Brennan C; Rende S; Wazen J
    Am J Otolaryngol; 2023; 44(5):103951. PubMed ID: 37329694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of postoperative speech comprehension with the transcutaneous partially implantable bone conduction hearing system Osia®.
    Arndt S; Wesarg T; Aschendorff A; Speck I; Hocke T; Jakob TF; Rauch AK
    HNO; 2024 Jan; 72(Suppl 1):1-9. PubMed ID: 37812258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®.
    Rauch AK; Wesarg T; Aschendorff A; Speck I; Arndt S
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4279-4288. PubMed ID: 34792628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Active Osseointegrated Implant System in Patients with Single-Sided Deafness.
    Willenborg K; Avallone E; Maier H; Lenarz T; Busch S
    Audiol Neurootol; 2022; 27(1):83-92. PubMed ID: 33902037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prediction of speech understanding with the transcutaneous partially implantable bone conduction hearing system Osia®. German Version].
    Arndt S; Wesarg T; Aschendorff A; Speck I; Hocke T; Jakob TF; Rauch AK
    HNO; 2024 Aug; 72(8):537-546. PubMed ID: 37589726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: Six-month results from a multicentre study.
    den Besten CA; Monksfield P; Bosman A; Skarzynski PH; Green K; Runge C; Wigren S; Blechert JI; Flynn MC; Mylanus EAM; Hol MKS
    Clin Otolaryngol; 2019 Mar; 44(2):144-157. PubMed ID: 30358920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant.
    Sprinzl G; Toner J; Koitschev A; Berger N; Keintzel T; Rasse T; Baumgartner WD; Honeder C; Magele A; Plontke S; Götze G; Schmutzhard J; Zelger P; Corkill S; Lenarz T; Salcher R
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1565-1579. PubMed ID: 36625869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance, safety, and patient-reported outcomes of an active osseointegrated bone-conduction hearing implant system at 24-month follow-up.
    Cowan R; Lewis AT; Hallberg C; Tong MCF; Birman CS; Ng IH; Briggs R
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):683-691. PubMed ID: 37552281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of a surgery and the short-term benefits of a new active bone conduction hearing implant - the Osia®.
    Gawęcki W; Gibasiewicz R; Marszał J; Błaszczyk M; Gawłowska M; Wierzbicka M
    Braz J Otorhinolaryngol; 2022; 88(3):289-295. PubMed ID: 32713797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of audiological outcomes and compliance between the Osia system and other bone conduction hearing implants.
    Kim Y; Choe G; Oh H; Choi BY
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2217-2224. PubMed ID: 36318324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Performance, Safety, and Patient-Reported Outcomes of an Active Osseointegrated Steady-State Implant System.
    Briggs R; Birman CS; Baulderstone N; Lewis AT; Ng IHY; Östblom A; Rousset A; Tari S; Tong MCF; Cowan R
    Otol Neurotol; 2022 Aug; 43(7):827-834. PubMed ID: 35878640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after Application of Active Bone Conducting Implants.
    Koro E; Werner M
    Audiol Neurootol; 2019; 24(4):197-205. PubMed ID: 31499490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Sophono bone-conduction system: Surgical, audiologic, and quality-of-life outcomes.
    Mclean T; Pai I; Philipatos A; Gordon M
    Ear Nose Throat J; 2017 Jul; 96(7):E28-E33. PubMed ID: 28719716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Clinical Investigation of a New Active Osseointegrated Steady-State Implant System.
    Mylanus EAM; Hua H; Wigren S; Arndt S; Skarzynski PH; Telian SA; Briggs RJS
    Otol Neurotol; 2020 Oct; 41(9):1249-1257. PubMed ID: 32925852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How I do it: Cochlear Osia 2 System surgery placement.
    Soloperto D; Dallari V; Molteni G
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):929-933. PubMed ID: 36271955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piezoelectric bone conduction hearing implant Osia® - audiological and quality of life benefits.
    Marszał J; Gibasiewicz R; Błaszczyk M; Gawłowska M; Gawęcki W
    Otolaryngol Pol; 2021 Jun; 75(6):11-22. PubMed ID: 35175219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Osia® 2 bone conduction hearing implant experience: Nationwide controlled-market release data and single-center outcomes.
    Goldstein MR; Bourn S; Jacob A
    Am J Otolaryngol; 2021; 42(1):102818. PubMed ID: 33166860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Performance Assessment of a New Active Osseointegrated Implant System in Mixed Hearing Loss: Results From a Prospective Clinical Investigation.
    Pla-Gil I; Redó MA; Pérez-Carbonell T; Martínez-Beneyto P; Alborch MO; Ventura AM; Monteagudo EL; Ribas IP; Algarra JM
    Otol Neurotol; 2021 Aug; 42(7):e905-e910. PubMed ID: 33710155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First United Kingdom experience of the novel Osia active transcutaneous piezoelectric bone conduction implant.
    Lau K; Scotta G; Wright K; Proctor V; Greenwood L; Dawoud M; Ray J
    Eur Arch Otorhinolaryngol; 2020 Nov; 277(11):2995-3002. PubMed ID: 32405815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.